Flynn James E
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Mgmt L.P.
DEERFIELD PARTNERS L.P.
Deerfield Private Design Fund III L.P.
Deerfield Mgmt III L.P.
Deerfield Healthcare Innovations Fund L.P.
Deerfield Mgmt HIF L.P.
Possible Member of 10% Group
10% Owner | 2020-05-01 08:31:18 | 2,254,567
0 | 2,254,567 | Form 13D |
ORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
Director
10% Owner | 2024-03-28 16:28:26 | 2,252,987
0 | 2,252,987 | Form 13D |
Novartis Institutes for BioMedical Research Inc.
NOVARTIS AG
10% Owner | 2020-03-10 12:20:08 | 1,979,226
0 | 1,979,226 | Form 13G |
SHAH MAHENDRA
Director | 2018-05-16 16:05:25 | 0
909,742 | 909,742 | Form 4/A |
Atlas Venture Fund X L.P.
ATLAS VENTURE ASSOCIATES X L.P.
Atlas Venture Associates X LLC
Atlas Venture Opportunity Fund I L.P.
Atlas Venture Associates Opportunity I L.P.
Atlas Venture Associates Opportunity I LLC
Atlas Venture Opportunity Fund II L.P.
Atlas Venture Associates Opportunity II LP
Atlas Venture Associates Opportunity II LLC
10% Owner | 2024-04-01 21:52:41 | 864,261
0 | 864,261 | Form 13D |
Vida Ventures LLC
VV Manager LLC
10% Owner | 2018-04-04 16:24:00 | 0
770,845 | 770,845 | Form 4 |
Rock Springs Capital Management LP
Rock Springs Capital Master Fund LP
Rock Springs Capital LLC
10% Owner | 2018-04-04 16:24:07 | 0
645,845 | 645,845 | Form 4 |
Chatterjee Saswati
10% Owner | 2018-03-27 18:02:57 | 475,014
0 | 475,014 | Form 3 |
Morrison Jodie Pope
CEO | 2024-03-27 17:36:51 | 394,445
0 | 394,445 | Form 4 |
Temasek Holdings (Private) Ltd
Fullerton Management Pte Ltd
Temasek Life Sciences Private Ltd
TLS Beta Pte. Ltd.
V-Sciences Investments Pte Ltd
10% Owner | 2024-10-25 06:06:25 | 313,943
0 | 313,943 | Form 13G |
Smith W Bradford
See remarks | 2023-02-27 16:05:27 | 249,000
0 | 249,000 | Form 4 |
Rasty Siyamak
Chief Operating Officer | 2019-07-11 16:30:42 | 222,707
0 | 222,707 | Form 4 |
Kalowski Lee
CFO and President | 2024-03-27 17:34:35 | 161,323
0 | 161,323 | Form 4 |
Seymour Albert
See Remarks | 2023-09-08 16:44:26 | 160,254
0 | 160,254 | Form 4 |
Blum Michael Lee
Chief Commercial Officer | 2023-02-27 16:05:45 | 121,000
0 | 121,000 | Form 4 |
Violette Shelia M.
Chief Scientific Officer | 2024-10-16 20:39:38 | 56,765
36,277 | 93,042 | Form 4 |
Campagna Jason
Chief Medical Officer | 2024-03-27 17:37:34 | 70,687
0 | 70,687 | Form 4 |
Kelly Timothy P
Chief Operating Officer | 2022-02-28 16:05:55 | 33,000
0 | 33,000 | Form 4 |
Iwicki Mark T
Director | 2024-03-27 17:40:32 | 25,534
0 | 25,534 | Form 4 |
REICIN ALISE
Director | 2023-06-15 18:04:26 | 23,000
0 | 23,000 | Form 4 |
Poulton Jeffrey V.
Director | 2023-06-15 18:09:39 | 23,000
0 | 23,000 | Form 4 |
Patterson Matthew R
Director | 2023-06-15 18:33:36 | 23,000
0 | 23,000 | Form 4 |
GILLIS STEVEN
Director | 2023-06-15 19:25:26 | 23,000
0 | 23,000 | Form 4 |
PARMAR KUSH
Director | 2022-06-17 16:05:20 | 18,000
0 | 18,000 | Form 4 |
Gregory Richard J.
Director | 2022-06-17 16:05:48 | 18,000
0 | 18,000 | Form 4 |
Wheeler Cameron
Director | 2019-06-11 19:33:33 | 0
15,580 | 15,580 | Form 4/A |
LAPORTE KATHLEEN
Director | 2024-03-27 17:35:49 | 12,767
0 | 12,767 | Form 4 |
Xu Diyong
Director
10% Owner | 2024-03-27 17:39:05 | 12,767
0 | 12,767 | Form 4 |
Thistle Mary
Director | 2024-03-27 17:33:55 | 12,767
0 | 12,767 | Form 4 |
Cohn Gabriel
Chief Medical Officer | 2022-01-12 16:05:24 | 11,339
0 | 11,339 | Form 4 |
TZIANABOS ARTHUR
Director | 2024-08-14 16:05:05 | 7,983
0 | 7,983 | Form 4 |
Jordan Julie
Chief Medical Officer | 2023-08-07 21:39:25 | 7,496
0 | 7,496 | Form 4 |
Manke Isaac
Director | 2024-09-30 06:01:05 | 2,627
0 | 2,627 | Form 4 |
Alloway Paul
See Remarks | 2024-04-23 17:03:07 | 2,596
0 | 2,596 | Form 4 |
GRAYZEL DAVID S.
Director | 2024-08-14 16:05:06 | 2,569
0 | 2,569 | Form 4 |
Lundberg Sven Ante
Director | 2024-09-27 21:57:24 | 1,316
0 | 1,316 | Form 4 |
Michaud Charles Jr
See Remarks | 2024-04-23 17:00:03 | 927
0 | 927 | Form 4 |
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner | 2024-11-14 17:46:10 | 0
0 | 0 | Form 13G |
ARCH Venture Fund VIII L.P.
ARCH Venture Fund VIII Overage L.P.
ARCH Venture Partners VIII L.P.
ARCH Venture Partners VIII LLC
BYBEE CLINTON
CRANDELL KEITH
NELSEN ROBERT
10% Owner | 2024-05-13 17:34:55 | 0
0 | 0 | Form 13G |